COVID-19 obscuring the diagnosis of ciclosporin-related posterior reversible encephalopathy syndrome

Tunis Med. 2024 Nov 5;102(11):838-839. doi: 10.62438/tunismed.v102i11.5286.

Authors

Sanda Mrabet¹, Achraf Jaziri¹, Maha Aroud¹, Dorsaf Zellama¹, Salma Naija², Sana Ben Amor², Alaa Souissi³, Hela Jemni³

Affiliations

¹ Department of Nephrology, Dialysis and Transplantation. Sahloul University Hospital. Sousse. Tunisia.
² Neurology Department. Sahloul University Hospital. Sousse. Tunisia.
³ Radiology Department. Sahloul University Hospital. Sousse. Tunisia.

PMID: 39564622
DOI: 10.62438/tunismed.v102i11.5286

Abstract

Non.

Publication types

Case Reports
Letter

MeSH terms

COVID-19* / diagnosis
Cyclosporine* / adverse effects
Female
Humans
Immunosuppressive Agents* / adverse effects
Male
Middle Aged
Posterior Leukoencephalopathy Syndrome* / chemically induced
Posterior Leukoencephalopathy Syndrome* / diagnosis

Substances

Cyclosporine
Immunosuppressive Agents